Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AllianceRx Walgreens Prime is a leading specialty and home delivery pharmacy that provides high-touch pharmacy services for patients with complex and chronic conditions. Formed as a joint venture between Walgreens and Prime Therapeutics in 2017, it became a wholly owned subsidiary of Walgreens Boots Alliance in 2022. The company offers specialized support for therapeutic areas such as oncology, multiple sclerosis, and inflammatory conditions, focusing on medication adherence and patient outcomes. They provide clinical programs, financial assistance coordination, and 24/7 access to pharmacists to ensure comprehensive care for patients requiring specialty medications. By leveraging Walgreens' extensive retail footprint and Prime Therapeutics' PBM expertise, the company streamlines the delivery of limited distribution drugs and orphan medications. Their services are designed to support both patients and providers through integrated digital platforms and personalized care management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AllianceRx Walgreens Prime.